| CTRI Number |
CTRI/2026/02/104553 [Registered on: 23/02/2026] Trial Registered Prospectively |
| Last Modified On: |
20/02/2026 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
Frequency and pattern of infections in patient with different rheumatological conditions |
|
Scientific Title of Study
|
Frequency and pattern of infection among different rheumatological conditions: A retrospective study at a tertiary care centre |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| Nil |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Savneet kaur Gill |
| Designation |
MBBS student |
| Affiliation |
|
| Address |
AIIMS Rishikesh
Dehradun
UTTARANCHAL
249203
India |
| Phone |
9518689319 |
| Fax |
|
| Email |
savneetgill543@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Savneet kaur Gill |
| Designation |
MBBS student |
| Affiliation |
|
| Address |
AIIMS Rishikesh
Dehradun
UTTARANCHAL
249203
India |
| Phone |
9518689319 |
| Fax |
|
| Email |
savneetgill543@gmail.com |
|
Details of Contact Person
Public Query
|
| Name |
Savneet kaur Gill |
| Designation |
MBBS student |
| Affiliation |
|
| Address |
AIIMS Rishikesh
Dehradun
UTTARANCHAL
249203
India |
| Phone |
9518689319 |
| Fax |
|
| Email |
savneetgill543@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Institutional ethics committee |
| Address |
Aiims rishikesh 249203 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Savneet |
Department of medicine |
Aiims rishikesh
Dehradun
UTTARANCHAL |
9518689319
savneetgill543@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M00-M99||Diseases of the musculoskeletal system and connective tissue, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
64.00 Year(s) |
| Gender |
Both |
| Details |
Patients with confirmed rheumatic disease diagnosis |
|
| ExclusionCriteria |
| Details |
Patients with incomplete medical records |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To determine prevalence of infections in hospitalised patients with rheumatic disease over a defined period |
To determine prevalence of infections in hospitalised patients with rheumatic disease over a defined period |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To analyze pattern of infection (site and causative organisms) |
|
| To assess impact of immunosuppressive agent on infection rates |
|
| To identify risk factors associated with infections |
|
| To evaluate clinical outcomes-length of hospital stay,ICU admission and in hospital mortality |
|
|
|
Target Sample Size
|
Total Sample Size="177"
Sample Size from India="177"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
10/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2"
Months="0"
Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Study ID 20190241791 Sex F 0 Age 47 Date of admission 01 07 2023 Date of discharge 08 07 2023 Hospital stay 7 Icu admission No 0 Diagnosis Rheumatoid arthritis and cellulitis CCI 2 Comorbidities diabetes hypertension Therapy type corticosteroids Drug name- prednisolone Dose 2.5 mg Infection yes 1 Site foot Organism klebsiella pneumonia Diagnostic method aerobic culture for pus swab MDR No Infection current WBC 11.9k Hb 10.1g Platelet 229k ESR 6.78 CRP NA Blood culture negative Urine culture negative Chest x ray not available Other investigation venous Doppler Icu admission no Mechanical ventilation no In hospital mortality no Cause of death not applicable |